Available now- a new protein biomarker panel for oncology
December 13, 2018. A new 92-plex protein panel containing a combination of established and exploratory markers focused on oncology is now available for immediate shipment as kits, or via our Analysis Service. This panel provides a perfect complement to our existing panel, Olink® ONCOLOGY II, enabling oncologists to measure 184 proteins in 2 dedicated panels. For the many researchers who take a wider approach to biomarker discovery, the new panel extends our total library to 1164 different high-quality protein assays.
Some of the established cancer-related biomarkers in the new panel include:
Cell surface A33 antigen (GPA33), Uniprot ID Q99795
B-cell receptor CD22 (CD22), Uniprot ID P20273
Pro-neuropeptide Y (NPY), Uniprot ID P01303
Allograft inflammatory factor 1 (AIF1), Uniprot ID P55008
Vascular endothelial growth factor receptor 1 (VEGFR1), Uniprot ID P17948
The 92 assays in the panel cover a range of disease types and biological processes relevant for oncology (as defined by DisGeNet), such as carcinogenesis (28 proteins) , tumor progression (16 proteins), solid tumors (9 proteins) and recurrent tumors (5 proteins).